All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B, Chronic-24009186

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	24009186	D144A	S	S	Hepatitis B, Chronic	R S	View
2	24009186	M133T	S	S	Hepatitis B, Chronic	R S	View
3	24009186	F134I	S	S	Hepatitis B, Chronic	G R S	View
4	24009186	L109P	S	S	Hepatitis B, Chronic	G R S	View
5	24009186	M103I	S	S	Hepatitis B, Chronic	G R S	View
6	24009186	S117R	S	S	Hepatitis B, Chronic	G R S	View
7	24009186	S136L	S	S	Hepatitis B, Chronic	G R S	View
8	24009186	G102S	S	S	Hepatitis B, Chronic	R S	View
9	24009186	G130S	S	S	Hepatitis B, Chronic	R S	View
10	24009186	I110L	S	S	Hepatitis B, Chronic	R S	View
11	24009186	I126S	S	S	Hepatitis B, Chronic	R S	View
12	24009186	I126T	S	S	Hepatitis B, Chronic	R S	View
13	24009186	L110I	S	S	Hepatitis B, Chronic	G R S	View
14	24009186	P127T	S	S	Hepatitis B, Chronic	R S	View
15	24009186	Q101K	S	S	Hepatitis B, Chronic	R S	View
16	24009186	T113S	S	S	Hepatitis B, Chronic	R S	View
17	24009186	T116N	S	S	Hepatitis B, Chronic	R S	View
18	24009186	Y100C	S	S	Hepatitis B, Chronic	G R S	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.